Components of IGF-axis in growth disorders: a systematic review and patent landscape report
- PMID: 35523998
- DOI: 10.1007/s12020-022-03063-2
Components of IGF-axis in growth disorders: a systematic review and patent landscape report
Abstract
Purpose: In this review, epi/genetic mutations of IGF-axis components associated with growth disorders have been summarized alongwith assessment of relevant diagnostic and therapeutic technology through patent literature.
Methodology: PROSPERO protocol registration CRD42021279468. For scientific literature search Literature databases (PubMed, EMBASE, ScienceDirect, and Google Scholar) were queried using the appropriate syntax. Various filters were applied based on inclusion and exclusion criteria. Search results were further refined by two authors for finalizing studies to be included in this synthesis. For patent documents search Patent databases (Patentscope and Espacenet) were queried using keywords: IGF or IGFBP. Filters were applied according to International Patent Classification (IPC) and Cooperative Patent Classification (CPC). Search results were reviewed by two authors for inclusion in the patent landscape report.
Results: For scientific literature analysis, out of 545 search results, 196 were selected for review based on the inclusion criteria. For Patent literature search, out of 485 results, 37 were selected for this synthesis.
Conclusion: Dysregulation of IGF-axis components leads to various abnormalities and their key role in growth and development suggests epi/mutations or structural defects among IGF-axis genes can be associated with growth disorders and may explain some of the idiopathic short stature cases. Trend of patent filings indicate advent of recombinant technology for therapeutics.
Keywords: Diagnosis; Growth disorders; Insulin-like growth factors; Patent; Therapeutics.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- B. Ergun-Longmire, M.P. Wajnrajch: Growth and Growth Disorders. In: K.R. Feingold, B. Anawalt, A. Boyce, G. Chrousos, W.W. de Herder, K. Dhatariya, K. Dungan, J.M. Hershman, J. Hofland, S. Kalra, G. Kaltsas, C. Koch, P. Kopp, M. Korbonits, C.S. Kovacs, W. Kuohung, B. Laferrère, M. Levy, EA. McGee, R. McLachlan, J.E. Morley, M. New, J. Purnell, R. Sahay, F. Singer, M.A. Sperling, C.A. Stratakis, D.L. Trence, and D.P. Wilson, (eds.) Endotext. MDText.com, Inc., South Dartmouth (MA) (2000).
-
- K. Forbes, M. Westwood, The IGF axis and placental function. Horm. Res. Paediatr. 69, 129–137 (2008). https://doi.org/10.1159/000112585 - DOI
-
- R. Peoples, A. Milatovich, U. Francke, Hemizygosity at the insulin-like growth factor I receptor (IGF1R) locus and growth failure in the ring chromosome 15 syndrome. Cytogenet. Cell Genet. 70, 228–234 (1995). https://doi.org/10.1159/000134040 - DOI - PubMed
-
- P. Prontera, L. Micale, A. Verrotti, V. Napolioni, G. Stangoni, G. Merla, A new homozygous IGF1R variant defines a clinically recognizable incomplete dominant form of SHORT syndrome. Hum. Mutat. 36, 1043–1047 (2015). https://doi.org/10.1002/humu.22853 - DOI - PubMed
-
- I. Castilla-Cortazar, J.R. de Ita, G.A. Aguirre, F. Castorena-Torres, J. Ortiz-Urbina, M. García-Magariño, R.G. de la Garza, C. Diaz Olachea, M.I. Elizondo Leal, Fanconi anemia and laron syndrome. Am. J. Med. Sci. 353, 425–432 (2017). https://doi.org/10.1016/j.amjms.2017.02.001 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
